From left: Myosana CEO Matthew Lumley, with co-founders Stanley Froehner and Nick Whitehead. (Myosana and UW Photos) The news: Myosana Therapeutics, a Seattle startup developing gene therapy ...
Duchenne muscular dystrophy (DMD) is a muscle degeneration disorder caused by mutations affecting the dystrophin gene. Researchers show how a dual CRISPR RNA method restored dystrophin protein ...
Spinal muscular atrophy affects all the body’s muscles. For a long time, it was considered a disease caused solely by the ...
Spinal muscular atrophy affects all the body's muscles. For a long time, it was considered a disease caused solely by the ...
"The most apparent take-away from the study findings is that a model of developmental therapy focusing on frequency, intensity, and variability of activity, exercise, and self-driven exploration may ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Fritz Frohse (1871-1916), a physician ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback